The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2015-03-30
DOI
10.1155/2015/731469
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Hepatocellular Carcinoma
- (2015) Kelly J. Lafaro et al. Surgical Oncology Clinics of North America
- EASL- and mRECIST-Evaluated Responses to Combination Therapy of Sorafenib with Transarterial Chemoembolization Predict Survival in Patients with Hepatocellular Carcinoma
- (2014) L. Liu et al. CLINICAL CANCER RESEARCH
- The PD-1 pathway as a therapeutic target to overcome immune escape mechanisms in cancer
- (2014) Brian S Henick et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin: Effect on Work Performance. A Randomized Clinical Trial
- (2014) Giulia Malaguarnera et al. Hepatitis Monthly
- Sorafenib use in hepatocellular carcinoma: More questions than answers
- (2014) Ghassan K. Abou-Alfa HEPATOLOGY
- Immune checkpoint blockade in hepatocellular carcinoma: Current progress and future directions
- (2014) Tai Hato et al. HEPATOLOGY
- Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma
- (2014) Tadaaki Arizumi et al. JOURNAL OF GASTROENTEROLOGY
- Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list
- (2014) Neil Mehta et al. LIVER TRANSPLANTATION
- Conundrum of treatment for early-stage hepatocellular carcinoma: Radiofrequency ablation instead of liver transplantation as the first-line treatment?
- (2014) Francis Y. Yao LIVER TRANSPLANTATION
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Telomere and telomerase in chronic liver disease and hepatocarcinoma
- (2014) Lucia Carulli WORLD JOURNAL OF GASTROENTEROLOGY
- Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis
- (2014) Hong-Qiang Zhao WORLD JOURNAL OF GASTROENTEROLOGY
- HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma
- (2014) Martin Jadus et al. OncoTargets and Therapy
- Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
- (2014) Roman L. Bogorad et al. Nature Communications
- Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study
- (2014) Adriana Toro et al. BMC Surgery
- Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
- (2014) Gaetano Bertino et al. Biomed Research International
- Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model
- (2014) S. Chen et al. Cancer Immunology Research
- Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression
- (2013) J Liang et al. BRITISH JOURNAL OF CANCER
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Systemic therapies in hepatocellular carcinoma: present and future
- (2013) Gaetano Bertino et al. Future Oncology
- Human CD14+CTLA-4+regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma
- (2013) Yanmei Han et al. HEPATOLOGY
- Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: Effect of patient and nonpatient factors
- (2013) Jessica A. Davila et al. HEPATOLOGY
- Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients
- (2013) Han Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- The role of MDSCs in hepatocellular carcinoma – in vivo veritas?
- (2013) Jörg Schrader JOURNAL OF HEPATOLOGY
- Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial
- (2013) Luana Calabrò et al. LANCET ONCOLOGY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carbohydrate 19.9 Antigen Serum Levels in Liver Disease
- (2013) Gaetano Bertino et al. Biomed Research International
- Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma
- (2012) Fei Zhao et al. DIGESTIVE DISEASES
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Current practice of chronic hepatitis B treatment in Southern Italy
- (2012) T. Stroffolini et al. European Journal of Internal Medicine
- Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC
- (2012) Mervat El Ansary et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Risk stratification for hepatitis B virus related hepatocellular carcinoma
- (2012) Chih-Lin Lin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- (2012) György Baffy et al. JOURNAL OF HEPATOLOGY
- Hepatocellualar Carcinoma Serum Markers
- (2012) Gaetano Bertino et al. SEMINARS IN ONCOLOGY
- Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature
- (2012) Isidoro Di Carlo et al. World Journal of Surgical Oncology
- Elevated serum levels of Chromogranin A in hepatocellular carcinoma
- (2012) Antonio Biondi et al. BMC Surgery
- Immunotherapy of hepatocellular carcinoma
- (2012) Angela D. Pardee et al. OncoImmunology
- Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis
- (2011) CosimoMarcello Bruno et al. ANNALS OF SAUDI MEDICINE
- Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion
- (2011) Danijela Petrovic et al. HEPATOLOGY
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review
- (2011) J.-H. Zhong et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- The Supplementation of Acetyl-l-Carnitine Decreases Fatigue and Increases Quality of Life in Patients with Hepatitis C Treated with Pegylated Interferon-α 2b Plus Ribavirin
- (2011) Michele Malaguarnera et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes
- (2011) Joel M. O'Bryan et al. PLoS One
- L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin
- (2011) Michele Malaguarnera WORLD JOURNAL OF GASTROENTEROLOGY
- NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery
- (2011) HENG XU et al. Oncology Letters
- A Therapeutic OX40 Agonist Dynamically Alters Dendritic, Endothelial, and T Cell Subsets within the Established Tumor Microenvironment
- (2010) A. D. Pardee et al. CANCER RESEARCH
- Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma
- (2010) R. Satow et al. CLINICAL CANCER RESEARCH
- Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis
- (2010) Gaetano Bertino et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response
- (2010) Céline Miroux et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
- (2010) Feng Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
- (2010) Tim F. Greten et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function
- (2010) Cheng-En Hu et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The Liver Is a Site for Tumor-Induced Myeloid-Derived Suppressor Cell Accumulation and Immunosuppression
- (2009) Dan Ilkovitch et al. CANCER RESEARCH
- Validation of TPX2 as a Potential Therapeutic Target in Pancreatic Cancer Cells
- (2009) S. L. Warner et al. CLINICAL CANCER RESEARCH
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Epidemiology of hepatocellular carcinoma in Japan
- (2009) Takeji Umemura et al. JOURNAL OF GASTROENTEROLOGY
- Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
- (2008) S. Tanaka et al. BRITISH JOURNAL OF SURGERY
- Phase I Safety and Pharmacokinetic Study of CT-011, a Humanized Antibody Interacting with PD-1, in Patients with Advanced Hematologic Malignancies
- (2008) R. Berger et al. CLINICAL CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- Comprehensive analysis of the α-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma
- (2008) Robert Thimme et al. HEPATOLOGY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Building a spindle of the correct length in human cells requires the interaction between TPX2 and Aurora A
- (2008) Alexander W. Bird et al. JOURNAL OF CELL BIOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started